← Open Payments lookup

JAMES GARVIN: Open Payments

NPI 1447641352 · AZLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$384 in 18 payments from 12 companies in 2025. Trend: 2023 $157 · 2024 $862 · 2025 $384

Food & beverage: $384
CompanyPaymentsAmount
GENZYME CORPORATION3$77
ARS Pharmaceuticals Operations, Inc.2$54
AstraZeneca Pharmaceuticals LP3$54
Phathom Pharmaceuticals, Inc.2$37
PFIZER INC.1$29
BioCryst US Sales Co., LLC1$27
Smith+Nephew, Inc.1$24
Takeda Pharmaceuticals U.S.A., Inc.1$21
Lilly USA, LLC1$18
Phadia US Inc.1$16

Products named: DUPIXENT, NEFFY, VOQUEZNA, AIRSUPRA, OCTAGAM IMMUNE GLOBULIN (HUMAN), ORLADEYO, Versajet, FASENRA.

Industry payments across TX — which companies pay providers there.